Skip to main content
. 2016 Aug 18;11(8):e0161098. doi: 10.1371/journal.pone.0161098

Table 1. Patient Characteristics by Duration of AKI (n = 1194).

Characteristic No AKI 0 days (n = 788) 1–2 days (n = 250) 3–6 days (n = 118) ≥ 7 days (n = 38) P value
Demographics
 Age at the time of surgery, mean (SD) 71.1 (10.3) 71.8 (9.8) 71.1 (10.3) 73.3 (7.7) 0.49
 Men 525 (67%) 176 (70%) 85 (72%) 29 (76%) 0.33
 White race 740 (94%) 235 (94%) 112 (95%) 31 (82%) 0.02
Medical History (prior to surgery)
 Diabetes 294 (37%) 95 (38%) 58 (49%) 24 (63%) <0.01
 Hypertension 605 (77%) 205 (82%) 102 (86%) 31 (82%) 0.05
 Congestive Heart Failure 175 (22%) 65 (26%) 49 (42%) 18 (47%) <0.01
 LVEF < 40% 77 (10%) 29 (12%) 11 (9%) 1 (3%) 0.37
 Previous myocardial infarction 197 (25%) 61 (24%) 36 (31%) 10 (26%) 0.61
 eGFR (mL/min per 1.73 m2), mean (SD) 69.2 (18.9) 66.4 (18.3) 61.3 (21.5) 57.2 (20.4) <0.01
 eGFR ≥ 60 548 (70%) 164 (66%) 56 (48%) 18 (47%) <0.01
 eGFR 30-<60 223 (28%) 79 (32%) 52 (44%) 18 (47%)
 eGFR < 30 17 (2%) 7 (3%) 10 (9%) 2 (5%)
 Pre-op Serum Creatinine§ (mg/dL), mean (SD) 1.05 (0.32) 1.10 (0.31) 1.23 (0.45) 1.30 (0.38) <0.01
 Urine albumin to Creatinine, mg/mmol
  < = 10.0 341 (43%) 83 (33%) 26 (22%) 6 (16%) <0.01
  10.0-<30 229 (29%) 74 (30%) 32 (27%) 12 (32%)
  30–300 188 (24%) 77 (31%) 43 (36%) 14 (37%)
  >300 30 (4%) 16 (6%) 17 (14%) 6 (16%)
Surgical Characteristics
 Elective Surgery 656 (83%) 190 (76%) 78 (66%) 26 (68%) <0.01
 Surgery
  CABG 392 (50%) 121 (48%) 52 (44%) 12 (32%) 0.03
  CABG & Valve 162 (21%) 56 (22%) 35 (30%) 16 (42%)
  Valve 234 (30%) 73 (29%) 31 (26%) 10 (26%)
 Off-pump 85 (11%) 20 (8%) 12 (10%) 6 (16%) 0.02
 Re-do surgery 14 (2%) 4 (2%) 1 (1%) 1 (3%) 0.87
 Perfusion time (minutes), mean (SD) 106.6 (52.7) 119.1 (59.6) 129.4 (74.2) 168.4 (91.3) <0.01
 Cross-clamp time (minutes), mean (SD) 72.7 (40.0) 80.7 (44.7) 90.9 (53.3) 114.4 (67.3) <0.01
 Number of Diseased Coronary Vessels
  None 219 (28%) 65 (26%) 26 (22%) 11 (29%) 0.78
  One 106 (14%) 35 (14%) 13 (11%) 2 (5%)
  Two 149 (19%) 47 (19%) 22 (19%) 6 (16%)
  Three 314 (40%) 103 (41%) 57 (48%) 19 (50%)
Post-operative Complications
 AKIN stage
  Stage 1 0 243 (97%) 95 (81%) 20 (53%)
  Stage 2 0 6 (2%) 14 (12%) 10 (26%)
  Stage 3 0 1(0%) 9 (8%) 8 (21%)
 Oliguria in first day, n (%) 8 (1%) 3 (1%) 2 (2%) 2 (5%) 0.31
 Delta Peak Serum creatinine (mg/dL), mean (SD) 0.03 (0.14) 0.37 (0.23) 0.75 (0.51) 0.98 (0.72) <0.01
 # Non-renal complications, n (%)
  0 507 (64%) 152 (61%) 63 (53%) 6 (16%) <0.01
  1–2 232 (29%) 77 (31%) 37 (31%) 14 (37%)
  >2 49 (6%) 21 (8%) 18 (15%) 18 (47%)
 Ventilator > 48 hours, n (%) 8 (1%) 11 (4%) 10 (8%) 16 (42%) <0.01
 ICU LOS, mean (SD) 2.32 (4.11) 3.41 (7. 419) 3.64 (3.90) 20.32 (32.75) <0.01
 Hospital LOS, mean (SD) 6.89 (5.29) 9.32 (11.34) 9.18 (4.86) 32.05 (35.09) <0.01

Data are presented as the mean (SD), n (%), or median (interquartile range) unless otherwise specified. eGFR, estimated GFR; SCr, serum creatinine.

§To convert serum creatinine values to millimoles per liter, multiply by 88.4.

Oliguria is defined as a patient who had 125 ml or 500 ml urine output in 6 or 24 hours, respectively.

Nonrenal complications are defined as reoperation, infection, neurologic, pulmonary, vascular, and other.